• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,488.96 1,073.61
( 1.42%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
65,182.04 1,842.97
(2.91%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.385578
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
30.54
113007.26
EPS(TTM)
Face Value()
Div & Yield %
45.81
2
0.93
 

vipul organics ltd
KIMS inks long term lease deal to establish multi-speciality hospital in Amaravati
May 11,2026
The agreement covers 2 acres of land in Amravati. The proposed multi-speciality hospital will offer comprehensive tertiary and quaternary care across cardiology, oncology, neurosciences, gastroenterology, orthopaedics, mother & child care, critical care, organ transplant and other key specialties, addressing a long-standing need for advanced healthcare infrastructure in the region.

Once operational, patients in Amaravati and surrounding districts of Andhra Pradesh will gain access to high-end clinical capabilities, reducing the need of travel to other metros for specialised care.

Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.

The company’s consolidated net profit declined 39.8% to Rs 53.40 crore despite of 29.2% increase in revenue from operations to Rs 997.70 crore in Q3 FY26 over Q3 FY25.

The counter advanced 1.41% to end at Rs 717.55 on the BSE.